0001601292-22-000003.txt : 20221101
0001601292-22-000003.hdr.sgml : 20221101
20221101162211
ACCESSION NUMBER: 0001601292-22-000003
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20221101
DATE AS OF CHANGE: 20221101
EFFECTIVENESS DATE: 20221101
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Embolx, Inc.
CENTRAL INDEX KEY: 0001601292
IRS NUMBER: 300790974
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-463522
FILM NUMBER: 221350537
BUSINESS ADDRESS:
STREET 1: 530 LAKESIDE DRIVE
STREET 2: SUITE 200
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
BUSINESS PHONE: 408-990-2949
MAIL ADDRESS:
STREET 1: 530 LAKESIDE DRIVE
STREET 2: SUITE 200
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
D
1
primary_doc.xml
X0708
D
LIVE
0001601292
Embolx, Inc.
530 LAKESIDE DRIVE
SUITE 200
SUNNYVALE
CA
CALIFORNIA
94085
408-990-2949
CALIFORNIA
None
None
Corporation
true
MICHAEL
ALLEN
530 Lakeside Drive
Suite 200
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Director
President & Chief Executive Officer
MICHAEL
LIN
530 Lakeside Drive
Suite 200
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Director of Finance
TOM
BRETON
530 Lakeside Drive
Suite 200
Sunnyvale
CA
CALIFORNIA
94085
Executive Officer
Manager of Research & Development
NORMAN
GITIS
530 Lakeside Drive
Suite 200
Sunnyvale
CA
CALIFORNIA
94085
Director
FRANK
GRILLO
530 Lakeside Drive
Suite 200
Sunnyvale
CA
CALIFORNIA
94085
Director
PAUL
ROGAN
530 Lakeside Drive
Suite 200
Sunnyvale
CA
CALIFORNIA
94085
Director
TIANHONG
XU
530 Lakeside Drive
Suite 200
Sunnyvale
CA
CALIFORNIA
94085
Director
Other
Decline to Disclose
- 06b
false
2022-10-19
false
true
true
false
0
Revere Securities LLC
14178
None
None
650 5th Avenue
35th Floor
New York
NY
NEW YORK
10019
CA
CALIFORNIA
FL
FLORIDA
MA
MASSACHUSETTS
false
1629000
1629000
0
false
5
130320
true
0
true
0
true
false
Embolx, Inc.
/s/ Michael Allen
Michael Allen
President and Chief Executive Officer
2022-11-01